Abstract
Objective: This study aimed to evaluate the predictive value of growth hormone (GH), insulin-like growth factor-1 (IGF-1), calcium (Ca), and phosphorus (P) levels in the first 2-4 days after surgery for achieving biochemical remission in patients with newly diagnosed acromegaly.
Methods: This retrospective cohort study included patients with acromegaly who underwent surgery. Preoperative and early postoperative days 2-4 (POD2-4), 3rd month, and 12th month serum levels of GH, IGF-1, Ca, and P were obtained. Age-normalized IGF-1 levels defined remission at 3-6 months, and patients were grouped accordingly.
Results: Biochemical remission was achieved in 44 of 68 patients (64.7%). Preoperative GH, IGF-1, and Ca were significantly higher in the non-remission group (all P < .05), while P did not differ. In POD2-4, all parameters, including P, were significantly higher in the non-remission group (P < .05). Receiver operating characteristic (ROC) analysis showed that a GH ≤1.28 in POD2-4 (AUC = 0.858, sensitivity: 0.74, specificity: 0.88) and a ≥45.29% decrease in IGF-1 from preoperative values (AUC = 0.816; sensitivity: 0.73, specificity: 0.79) predicted remission. At 12 months, GH and IGF-1 remained significantly different, whereas Ca and P did not (P = .67 and P = .20).
Conclusion: In patients with acromegaly, GH, IGF-1, Ca, and P levels measured in the first 2-4 days after surgery were found to be significantly lower in the remission group than in those who did not achieve remission. Postoperative GH levels and the percentage decrease in IGF-1 levels were associated with remission and may help with early risk stratification.
Cite this article as: Babayeva A, Coskun M, Ozturk O, et al. The evaluation of the predictive value of early postoperative biochemical parameters for remission in patients with acromegaly. Endocrinol Res Pract. Published online September 1, 2026. doi: 10.5152/erp.2026.26985

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.